Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ascend Wellness Holdings (AAWH) Cash & Equivalents (2020 - 2025)

Ascend Wellness Holdings has reported Cash & Equivalents over the past 6 years, most recently at $85.7 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $85.7 million for Q4 2025, down 2.92% from a year ago — trailing twelve months through Dec 2025 was $85.7 million (down 2.92% YoY), and the annual figure for FY2025 was $85.7 million, down 2.92%.
  • Cash & Equivalents for Q4 2025 was $85.7 million at Ascend Wellness Holdings, down from $87.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for AAWH hit a ceiling of $155.5 million in Q4 2021 and a floor of $646000.0 in Q1 2021.
  • Median Cash & Equivalents over the past 5 years was $85.7 million (2025), compared with a mean of $87.7 million.
  • Peak annual rise in Cash & Equivalents hit 22159.6% in 2022, while the deepest fall reached 52.31% in 2022.
  • Ascend Wellness Holdings' Cash & Equivalents stood at $155.5 million in 2021, then tumbled by 52.31% to $74.1 million in 2022, then dropped by 2.21% to $72.5 million in 2023, then rose by 21.72% to $88.3 million in 2024, then decreased by 2.92% to $85.7 million in 2025.
  • The last three reported values for Cash & Equivalents were $85.7 million (Q4 2025), $87.3 million (Q3 2025), and $95.3 million (Q2 2025) per Business Quant data.